Elevation Oncology Inc (ELEV) Financials

$0.37

$0.00 (0.00%)

As on 01-Aug-2025 09:30EDT

Market cap

$22 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	0.04	--	--	--	--	--
Cost of Revenue	0.03	0.02	0.04	0.03	0.02	0.02
Gross Profit	0.01	-0.02	-0.04	-0.03	-0.02	-0.02
Operating Expenses	45.67	44.70	45.45	94.55	32.05	17.28
Operating Profit (EBIT)	-49.05	-44.70	-45.45	-94.55	-32.05	-17.28
Other Income	--	--	--	-0.51	--	--
Profit before Tax	-47.95	-44.44	-45.67	-95.06	-32.04	-17.27
Provision for Tax	0.04	0.04	0.03	0.03	-0.22	-0.19
Profit after Tax (Net Income)	-47.99	-44.49	-45.70	-95.08	-32.04	-17.27
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-95.08	-32.04	-17.27

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	46.73	60.03	54.81	49.03	140.70	-23.08
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	31.25	31.13	30.14	29.44	0.01	97.20
Current Liabilities	4.24	4.47	4.15	15.69	8.79	6.79
Total Liabilities	86.46	95.63	89.09	94.16	149.49	80.91

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	0.03	0.90	1.13	1.18	0.07	0.12
Current Assets	82.19	94.73	87.96	92.98	149.42	80.79
Total Assets	86.46	95.63	89.09	94.16	149.49	80.91
Total Debt*	31.25	31.13	30.14	29.44	--	--
Net Current Assets	77.96	90.26	83.82	77.29	140.64	74.00

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-36.36	-56.18	-85.48	-30.17	-12.30
Cash Flow from Investing Activities	--	-8.37	11.54	-44.40	-44.40	-0.07
Cash from Financing Activities	--	44.94	47.98	29.51	97.05	90.03
Net Cash Inflow / Outflow	--	--	--	-100.37	--	--

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-0.81	-0.75	-1.08	-4.08	-2.64	-1.04
Cash EPS ($)	--	-0.75	-1.08	-4.08	-2.64	-1.04
Adjusted Book Value ($)	--	1.02	1.29	2.10	11.60	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.62	-1.32	-3.67	-2.49	-0.74
Free Cash Flow per Share ($)	--	-0.62	-1.32	-3.67	-2.49	-0.75

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-50.52	-55.94	-86.77	-54.48	119.26
ROE (%)	-82.68	-77.48	-88.03	-100.23	-54.48	119.26
ROA (%)	-48.53	-48.17	-49.88	-78.04	-27.81	-41.69
EBIT Margin (%)	-126,005.26	--	--	--	--	--
Net Margin (%)	-126,286.84	--	--	18,790.51	--	--
Cash Profit Margin (%)	-6.65	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-34.48	--	--	--	--	--
EBIT Growth (%)	-24.15	-4.18	56.10	-195.04	-85.61	-82.60
Net Profit Growth (%)	-21.95	2.67	51.93	-196.76	-85.57	-193.52
EPS Growth (%)	21.16	0.30	0.74	-0.55	-1.53	--
Book Value Growth (%)	-50.65	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.75	-0.50	-0.23	-2.28	--
Price / Book Value	0.46	0.55	0.42	0.45	0.52	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-3.08	0.64	0.73	0.41	2.29	--
Close Price ($)	0.26	0.56	0.54	0.95	6.02	--
High Price ($)	5.83	5.83	5.89	6.87	16.22	--
Low Price ($)	0.24	0.50	0.36	0.86	4.15	--
Market Cap ($ Cr)	21.63	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	0.67	0.52	0.55	0.60	--	--
Short term debt to equity ratio	--	--	--	--	--	--
Current Ratio	19.40	21.21	21.22	5.93	17.00	11.91
Quick Ratio	19.40	--	--	--	--	--
Interest Coverage	-11.39	-10.82	-9.96	-197.39	-4,578.00	--

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	0.00	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	--	--	--
Payable days	--	8,111.59	32,165.41	81,234.31	114,921.85	74,742.33
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.